Republic of Palau Comprehensive Cancer Control Plan

Objectives

Palau’s 2018–2023 Comprehensive Cancer Control Plan sets the vision “Cancer Free Me, Cancer Free Communities, Cancer Free Nation” and seeks to reduce cancer incidence, morbidity and mortality, improve survivors’ quality of life, and reduce cancer-related health disparities.[1][2]It frames cancer control around prevention, screening, treatment, survivorship and quality of life, and health disparity, using environmental action, community-clinical linkages and health-system change as its strategic approaches.[1][2]

• Reduce preventable cancer risks by addressing tobacco and alcohol use, obesity, physical inactivity, poor nutrition, and cancer-associated infections, while expanding human papillomavirus and hepatitis B vaccination.[3][4][5]
• Detect screenable cancers earlier through breast, cervical and colorectal screening, with targets to increase colorectal screening from 5% to 10% by 2023, cervical screening from 60% to 80% by 2022, and breast screening from 30% to 50% by 2022.[6]
• Improve access to available, accessible, cost-effective and comprehensive treatment, including increasing the proportion of patients receiving medically appropriate treatment and services within 90 days of diagnosis.[6][7]
• Strengthen survivorship support, palliative care and follow-up, including increasing access to support services and the proportion of survivors living for more than five years after diagnosis.[7][8]
• Address disparities affecting urban and outer-island populations, whose access to cancer services is shaped by historical, social, cultural, environmental, economic and geographic factors.[9]
• Prioritise major cancer burdens, including lung and bronchus, liver, prostate, oral cavity and pharynx, uterine, colorectal, breast, cervical, thyroid and stomach cancers.[1][10]

Implementation

The plan is an annex to the Palau Non-Communicable Diseases Plan and is implemented through the Ministry of Health, the National Comprehensive Cancer Control Program, the Palau Cancer Coalition, and the National Coordinating Mechanism for Non-Communicable Diseases.[1][11]Delivery combines public-health prevention and screening, community outreach, hospital services, off-island referral where required, multi-sector partnerships, workforce development and use of data to guide action.[12][2][5]

• Deliver community services through six community health centres serving the Northern, Western, Eastern, Southern, Airai and Central regions, including designated outer states.[9]
• Provide prevention and early-detection services through public education, human papillomavirus and hepatitis B vaccination, mammography, Pap tests, colorectal screening and the Breast and Cervical Cancer Early Detection Program.[12]
• Use evidence-based screening and diagnostic methods, including clinical breast examination, mammography, Pap testing, visual inspection with acetic acid, human papillomavirus DNA testing, faecal occult blood testing, flexible sigmoidoscopy and colonoscopy.[13]
• Manage selected early-stage cancers on-island through limited surgical services and maintenance chemotherapy, while referring patients to the Philippines, Taiwan or Hawaii for diagnostic confirmation, staging or treatment not available locally.[10]Referral decisions depend on disease stage, progression and available resources.[9][12]
• Develop comprehensive case management through service mapping, protocols and case-manager recruitment, and establish a Ministry of Health cancer Service Center through hospital-space identification, support mobilisation and furnishing.[7]
• Strengthen survivorship through a multidisciplinary team, survivor guidelines, navigation processes, culturally appropriate directories of social support services, and training for health workers and family caregivers.[7][8]The Family Caregiver Course developed by the University of Hawaii is routinely delivered through Palau Community College.[10][3]
• Mobilise a coalition spanning public, private and non-profit sectors, including public-health programmes, the Palau Cancer Registry, survivors, caregivers, community organisations, youth, education, media, faith-based groups and government representatives.[2][14]Additional partners include the University of Hawaii, Centers for Disease Control and Prevention, Cancer Council of the Pacific Islands and Pacific Islands Health Officers Association.[15][16]
• Build implementation capacity through culturally appropriate education materials, communications campaigns, collaboration between public-health programmes, skills-needs assessments, telehealth-related training and community champions.[2][5]
• Use the Palau Cancer Registry to inform resource priorities, screening, outreach and policy change; registry data are used by policymakers, public-health programmes and community coalitions.[3]
• Monitor progress through screening-coverage targets, capacity and barrier assessments, reviews of support and treatment services, training assessments, and evaluation of survivorship navigation processes.[6][7][8]The plan is intended to be evaluated and updated over time, although the supplied material does not specify a consolidated indicator framework, reporting timetable or formal accountability mechanism.[11][2][8]
• Secure resources for pilot screening, case management, extended mammography hours, training, the cancer Service Center and off-island treatment access.[6][7][8]United States federal funding supplies most dedicated health-service funding, supplemented by local funds, but limited budgets and workforce capacity constrain diagnosis, treatment and referral.[9][12]

Monitoring & Evaluation

Monitoring and evaluation combine use of cancer-registry data, targeted assessments and time-bound screening targets, but the plan does not provide a single consolidated performance framework, reporting timetable or formal accountability system.[3][5][6]The plan is intended to be dynamic, with regular evaluation and updating over time.[11]

• Use Palau Cancer Registry data to inform resource priorities, screening programmes, outreach, policy change and Ministry of Health improvements.[3]Respond to registry data requests from the Non-Communicable Disease Coalition, Cancer Coalition, Ministry of Health Quality Assurance Officer and local physicians.[3]
• Use data to guide interventions and monitor progress across cancer prevention and control activities.[2]Cancer data presented cover 2007 to 2015 and include adult cancer counts, selected cancer sites, tobacco- and obesity-related cancers, screening-test availability, years from diagnosis and stage at diagnosis.[4]
• Track screening and incidence objectives, including reducing the proportion of screenable cancers from 27% to 26% by 2021, increasing colorectal screening from 5% to 10% by 2023, cervical screening from 60% to 80% by 2022, and breast screening from 30% to 50% by 2022.[6]
• Assess screening capacity and barriers, treatment services, social-support services, workforce training needs, case-management arrangements and survivorship processes to identify gaps.[6][7][8]Evaluate survivorship guidelines and navigation processes following implementation, and strengthen treatment-plan processes for formal survivor follow-up.[8]
• Conduct focused prevention assessments, including reviews of obesity messages and resources, assessments of immunisation needs, surveys of smoking habits among people aged 12 to 18 years, and follow-up assessment of smoking-campaign effectiveness.[5]
• Recognise data-quality limitations, as constraints in screening and diagnosis may lead to under-reporting of some cancers.[10]Partnership activity has reportedly improved community awareness and screening, although substantial cancer disparities persist.[12]
• Assign implementation responsibility to the Palau Comprehensive Cancer Control Programme, community partners in the Palau Cancer Coalition and the National Coordinating Mechanism for Non-Communicable Diseases.[11]The source does not specify indicator definitions beyond the cited targets, routine reporting responsibilities, surveillance protocols, data sources for all measures, independent evaluation arrangements or enforcement mechanisms.[11][6][8]

Costing & Financing

Financing information is limited: the plan received support from the United States Centers for Disease Control and Prevention, while United States federal funding provides most dedicated health-service funding and local funds supplement this support.[1][12]Resource constraints, particularly limited health budgets, workforce capacity and referral funding, affect access to cancer diagnosis and treatment.[9][12][10]

• Mobilise additional resources, which remains a stated priority alongside reliance on United States federal and local funding.[12]The source does not quantify the respective federal or local contributions.[12]
• Address the limited budget for off-island referrals, which restricts access to diagnostic confirmation, advanced staging and advanced treatment.[10]Referral decisions depend on cancer stage, disease progression and available resources, and patients may be referred to the Philippines, Taiwan or Hawaii because definitive cancer treatment is unavailable in Palau.[9][12]
• Support planned resource needs for screening and treatment, including fiscal and political backing for a pilot screening programme, recruitment of case managers, extended mammography clinic hours, training resources, hospital space and furnishing for a cancer Service Center, and support for off-island treatment access.[6][7][8]
• Note the reported comparison in per-capita health expenditure: 1,310 United States dollars in Palau and more than 10,348 United States dollars in the United States.[12]These figures are presented as contextual expenditure data rather than a costed cancer-control budget.[12]
• Recognise that no total programme budget, costed workplan, activity-level allocation, quantified funding gap, unit cost, financing timeframe or economic assumption is specified in the supplied material.[1][10][6]